• LAST PRICE
    2.6700
  • TODAY'S CHANGE (%)
    Trending Down-0.0900 (-3.2609%)
  • Bid / Lots
    2.6300/ 1
  • Ask / Lots
    2.7000/ 1
  • Open / Previous Close
    2.7500 / 2.7600
  • Day Range
    Low 2.6200
    High 2.7500
  • 52 Week Range
    Low 1.7800
    High 5.1100
  • Volume
    172,390
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.76
TimeVolumeSYBX
09:32 ET9092.7
09:34 ET7072.7
09:39 ET36422.7
09:41 ET2222.65
09:43 ET2852.651
09:50 ET1682.688
09:59 ET5352.6601
10:03 ET1002.65
10:08 ET50002.64
10:10 ET26472.64
10:14 ET22002.6698
10:15 ET20002.6698
10:21 ET3002.665
10:28 ET6002.68
10:32 ET5002.68
10:35 ET3002.7
10:37 ET2002.7
10:39 ET3002.7
10:42 ET4002.7
10:44 ET2002.7
10:46 ET41002.71
10:48 ET3002.71
10:50 ET6772.74
10:53 ET2002.74
10:55 ET10002.73
11:06 ET6002.701
11:08 ET5002.73
11:09 ET1002.73
11:13 ET10002.73
11:15 ET8942.75
11:22 ET5452.73
11:26 ET2002.72
11:27 ET101002.7
11:29 ET73002.71
11:33 ET65552.69
11:36 ET2882.675
11:38 ET1002.675
11:40 ET3002.675
11:42 ET18742.6799
11:49 ET15002.65
12:02 ET1002.65
12:03 ET1002.65
12:07 ET26302.65
12:16 ET2002.655
12:18 ET24002.65
12:23 ET15002.6401
12:36 ET11002.655
12:43 ET5002.64
12:45 ET5002.65
12:48 ET111102.64
12:52 ET2002.63
12:54 ET2002.62
12:59 ET1002.62
01:01 ET59042.64
01:15 ET7252.64
01:17 ET4002.63
01:21 ET4002.64
01:28 ET28002.63
01:30 ET9002.63
01:32 ET12502.63
01:39 ET19002.64
01:44 ET27002.65
01:46 ET2002.64
01:48 ET10002.65
01:51 ET2002.64
01:53 ET10002.65
01:55 ET10002.65
01:57 ET3002.64
02:00 ET4002.64
02:02 ET13002.64
02:04 ET25402.64
02:08 ET10002.64
02:09 ET12002.64
02:11 ET10002.64
02:15 ET16002.64
02:18 ET6002.64
02:20 ET15702.63
02:22 ET2002.64
02:24 ET45852.64
02:26 ET48892.64
02:33 ET16022.64
02:36 ET67002.645
02:38 ET1002.64
02:40 ET2802.64
02:45 ET34992.62
02:47 ET22002.64
02:49 ET2002.64
02:51 ET55002.64
02:54 ET14152.64
02:56 ET3002.64
02:58 ET10602.65
03:00 ET3002.65
03:02 ET3002.65
03:03 ET10002.65
03:05 ET9002.65
03:07 ET4002.65
03:14 ET4002.66
03:16 ET7002.66
03:18 ET1002.665
03:20 ET3002.66
03:21 ET2002.67
03:27 ET14002.66
03:32 ET2002.67
03:39 ET5002.65
03:41 ET6002.66
03:43 ET23002.66
03:45 ET1002.66
03:48 ET9972.661
03:50 ET18052.67
03:52 ET12002.66
03:54 ET1002.67
03:56 ET4002.66
03:57 ET11972.67
03:59 ET16392.67
Data delayed at least 15 minutes.

Oct 15, 2021

Oct 13, 2021

Sep 27, 2021

6:30AM ET on Monday Sep 27, 2021 by PR Newswire

Sep 23, 2021

9:22AM ET on Thursday Sep 23, 2021 by MT Newswires
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSYBX
Synlogic Inc
139.8M
-1.9x
---
United StatesLBPH
Longboard Pharmaceuticals Inc
139.4M
-5.4x
---
United StatesSVRA
Savara Inc
137.8M
-2.0x
---
United StatesBIVI
BioVie Inc
139.1M
-0.3x
---
United StatesCALA
Calithera Biosciences Inc
138.6M
-1.7x
---
United StatesVBLT
Vascular Biogenics Ltd
146.6M
-4.6x
---
As of 2021-10-23

Company Information

Synlogic, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the drug discovery and development of Synthetic Biotic medicines. Its product pipeline includes Synthetic Biotic medicines for the treatment of metabolic disorders including Phenylketonuria (PKU) and Enteric Hyperoxaluria. The Company's lead product candidate includes SYNB1618, which is an oral therapy for the treatment of PKU. Its other product candidate SYNB8802 is developed for the treatment of Enteric Hyperoxaluria. The Company developed Synthetic Biotic medicines to treat certain cancers that are designed to modify the tumor microenvironment, activate the immune system and result in tumor reduction. It is developing SYNB1891 for the treatment solid tumors and lymphoma. The Company is conducting Phase II clinical trial with SYNB1618.

Contact Information

Headquarters
301 Binney St Ste 402CAMBRIDGE, MA, United States 02142-1030
Phone
617-401-9975
Fax
302-655-5049

Executives

Independent Chairman of the Board
Peter Barrett
President, Chief Executive Officer, Director
Aoife Brennan
Interim Chief Financial Officer
Gregg Beloff
Senior Vice President, Head of Finance
Daniel Rosan
Chief Operating Officer, Head of Technical Operation
Antoine Awad

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$139.8M
Revenue (TTM)
$246.0K
Shares Outstanding
52.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.55
EPS
$-1.39
Book Value
$3.02
P/E Ratio
-1.9x
Price/Sales (TTM)
568.4
Price/Cash Flow (TTM)
---
Operating Margin
-23,453.66%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.